Novavax (NVAX, $4.47) was one of top quarterly gainers, jumping +1 to $4.47 per share. A.I.dvisor analyzed 910 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.